Back to top

Analyst Reiterates Buy on Alnylam, Maintains $510 Price Target on Pipeline and Growth Optionality

Needham analyst Joseph Stringer has maintained their bullish stance on ALNY stock, giving a Buy rating on June 22. Joseph Stringer has given his Bu...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alnylam Pharmaceuticals, Inc. (ALNY)